Sucampo Pharma, Ltd Gets U.K. Approval for AMITIZA in Chronic Idiopathic Constipation
9/12/2012 7:56:00 AM
More...
|
Sucampo Pharma, Ltd to Release Fourth Quarter and Full Year 2009 Financial Results and Conduct a Conference Call on March 15, 2010
3/2/2010 11:21:28 AM
More...
|
Sucampo Pharma, Ltd Reports Top-Line Results of Phase 2 Clinical Trial of Cobiprostone for Prevention of NSAID-Induced Gastrointestinal Injuries
7/6/2009 10:01:44 AM
More...
|
Sucampo Pharma, Ltd Initiates Phase 1 Study of SPL-017 for Peripheral Arterial Disease
12/18/2008 11:03:03 AM
More...
|
Sucampo Pharma, Ltd, a Subsidiary of Sucampo Pharmaceuticals, Inc., Announces Start of Phase 2b Study in Japan to Evaluate Lubiprostone for Chronic Idiopathic Constipation
11/29/2007 9:37:22 AM
More...
|
Sucampo Pharma, Ltd Appoints New President and CEO
11/6/2007 7:03:08 AM
More...
|